What is S-Matrix?
S-Matrix Corporation specializes in the Fusion QbD Software Platform, an expert-system guided solution for statistical Design of Experiments (DOE) and multivariate data analysis within a Quality by Design framework. This platform is instrumental for major pharmaceutical entities worldwide, facilitating analytical method development, validation, and transfer, alongside formulation and process development. Regulatory bodies also leverage S-Matrix's technology to modernize methods and validate the robustness of pharmaceutical submissions. The company also provides services related to LC method development and software compliance.
How much funding has S-Matrix raised?
S-Matrix has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for S-Matrix?
The substantial capital infusion, particularly the recent strategic investment, positions S-Matrix for accelerated growth and enhanced market penetration. This funding is expected to fuel further innovation in their QbD software solutions, potentially expanding their service offerings and deepening their integration with pharmaceutical R&D and regulatory processes. The company's focus on advanced statistical analysis and QbD principles aligns with the industry's increasing demand for data-driven, compliant, and efficient drug development lifecycles.
See full S-Matrix company page
